Articles

Axhidrox: Europe’s First Hyperhidrosis Cream at Lecheng

2026-08-07T18:46:07+08:00

Axhidrox, the first topical glycopyrronium cream for severe axillary hyperhidrosis, cuts sweating by 82% with minimal side effects. Approved in Europe, the US, and now available in China via Lecheng's pilot zone. Discover the non-invasive solution today.

Axhidrox: Europe’s First Hyperhidrosis Cream at Lecheng2026-08-07T18:46:07+08:00

Dexycu: China’s First Single-Injection Cataract Drug via Lecheng RWD

2026-08-07T18:45:39+08:00

Discover Dexycu, the first single‑injection sustained‑release steroid for post‑cataract inflammation, now approved in China via Lecheng's real‑world data pathway. No more eye drops – one injection heals for 3 weeks.

Dexycu: China’s First Single-Injection Cataract Drug via Lecheng RWD2026-08-07T18:45:39+08:00
Go to Top